Eric Venker $ROIV SEC Form 4 Insider Trading

Eric Venker has filed a total of 87 insider trades in $ROIV since 2021. Their most recent trade was a sale of 46,234 shares, made on Jun 24, 2026. Their largest trade was a sale of 683,818 shares, made on Sep 19, 2025. We estimate that they now own 9.8 million shares of $ROIV, worth an estimated $57.7 million.

Insider Trading at $ROIV

There have been a total of 281 insider trades reported at $ROIV since 2021, with 4.0 million shares purchased and 175.6 million shares sold. The most active insider traders in $ROIV stock have been Eric Venker, Eric Venker, and Rakhi Kumar. The most recent trade was a sale of 10,000 shares reported by Meghan Fitzgerald (None), made on Jun 30, 2026.

$ROIV Executives and Stock Owners with Insider Trades

• Eric Venker, President & COO

• Eric Venker, President & Immunovant CEO

• Rakhi Kumar, Chief Accounting Officer

• Matthew Gline, CEO

• Eric Venker, Chief Operating Officer

• Mayukh Sukhatme, President & CIO

• Mayukh Sukhatme, Pres&Chief Investment Officer

• Frank Torti, President and Vant Chair

• Richard Pulik, CFO

• Jennifer Humes, Chief Accounting Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.